<http://schema.org/description>
"Breaking up is supposed to be hard to do, but it happens often enough in the diabetes space. After a disappointing run with multiple drugs and rising FDA demands for new drugs, Bristol-Myers"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/12/21/bristol-myers-squibb-and-astrazeneca-a-big-break-u/20793477/?gen=1>